Table 3.
Decellularization Methods for Peripheral Nervous System (PNS) Applications.
| Application | Study model | Source Tissue | Additional Components |
Post Processing | Decellularization Method | Notable Results | References | |||
|---|---|---|---|---|---|---|---|---|---|---|
| # | Step | Time | RPM | |||||||
| Transection and gap | In vitro analysis of decellularization | Rat sciatic nerve | N/A | N/A | Sondell et al. 1998 Method | Direct method comparison: Sondell’s method disrupted the nerve ECM more than the Hudson method. This disruption could be from shrinkage/swelling cycles when applying deoxycholate/water. Hudson’s method produced more demyelination and improved adhesive ratios. | [143,144,146,150-152,154] | |||
| distilled water | 7 h | |||||||||
| 2x | 3% Triton X-100 | 12 h | ||||||||
| 4% Sodium deoxycholate distilled water | 24 h | yes* | ||||||||
| Hudson et al. 2004 Method | ||||||||||
| distilled water | 7 h | |||||||||
| 125 mM sulfobetaine-10 | 15 h | yes* | ||||||||
| 50 mM phosphate and 100 mM sodium | 15 m | |||||||||
| 0.14% Triton X-200, 0.6 mM sulfobetaine-16, 10 mM phosphate and 50 mM sodium | 24 h | yes* | ||||||||
| 3x | 50 mM phosphate and 100 mM sodium | 5 m | ||||||||
| 125 mM sulfobetaine-10 | 7 h | yes* | ||||||||
| 50 mM phosphate and 100 mM sodium | 15 m | |||||||||
| 0.14% Triton X-200, 0.6 mM sulfobetaine-16, 10 mM phosphate and 50 mM sodium | 15h | |||||||||
| 3x | 50 mM phosphate and 100 mM sodium | 15 m | ||||||||
| 1.5 cm rat sciatic nerve defect | Rat sciatic nerve | N/A | N/A | Distilled water | 7 h | yes* | Decellularized similarly to Hudson’s method with increased ECM preservation. Outperformed Hudson’s method in nerve histomorphometry and muscle mass. Outperformed by autograft. | [158] | ||
| 1 M Sodium chloride | 15 h | yes* | ||||||||
| 2.5 nM Triton X-100 | 24 h | yes* | ||||||||
| 1X PBS | 15 m | yes* | ||||||||
| Distilled water | 7 h | yes* | ||||||||
| 1 M Sodium chloride | 15h | yes* | ||||||||
| 100 nM CHAPS | 24 h | yes* | ||||||||
| 5x | 1X PBS | 5 m | yes* | |||||||
| In vitro characterization and effect on PC12 cells | Rat sciatic nerve | N/A | axially aligned channels | 2x | distilled water | 7 h | Decellularization significantly increased pore size and created axially aligned channels. In vitro work showed enhanced PC12 cell migration both in number and depth into the graft. | [147] | ||
| 3% Triton X-100 | 12 h | yes* | ||||||||
| 2% deoxycholic acid in 50 nM Trizma base | 24 h | yes* | ||||||||
| DNase and RNase (5 U/ml) in 10 nM magnesium chloride | 12 h | |||||||||
| 0.1% peracetic acid | 1 h | |||||||||
| 3.5 cm Rat sciatic nerve gap defect | Rat sciatic nerve | N/A | N/A | DMEM 10% FBS 2% pen/strep/amph PBS | 2wks | yes* | Nerve autograft outperformed both the detergent free and detergent decellularized grafts. Only nerve autograft and detergent free grafts showed muscular recovery. | [186] | ||
| 1wk | yes* | |||||||||
| In vitro characterization and subcutaneous implantation | Rat sciatic nerve | Apoptosis assisted | N/A | DMEM with camptothecin (5 or 10uM) 37 °C | 1-3d | 14 | The apoptosis-assisted method maintained basal lamina microarchitecture with decreased cytotoxicity. | [171] | ||
| 4X PBS | 24 h | |||||||||
| 2X PBS | 30 m | |||||||||
| 3x | 1X PBS | 30 m | Also, inflammatory infiltrate and stromal remodeling decreased compared to autograft control. | |||||||
| 75 U/mL DNase | 36 h | |||||||||
| 2x | 1X PBS | 30 m | ||||||||
| In vitro characterization | Rat sciatic nerve | N/A | N/A | 2x | 10 mM TRIS-HCl; pH 8.0 | yes* | Reduced DNA content by greater than 95% while preserving collagen, laminin, and fibronectin. | [126] | ||
| 0.1% SDS with 10 kIU/mL | yes* | |||||||||
| 3x | 1X PBS | 30 m | yes* | |||||||
| 1 U/mL Benzonase | 3 h | yes* | ||||||||
| 1.5 M NaCl | yes* | |||||||||
| 0.1% peracetic acid in PBS | 3 h | yes* | ||||||||
| 3x | 1X PBS at 4C | 30 m | yes* | |||||||
| 1X PBS at 4C | 48 h | yes* | ||||||||
| 1 cm and 1.5 cm rat sciatic nerve defect models | Rat sciatic nerve and rabbit median nerve | N/A | N/A | 1X PBS | Allogeneic and xenogeneic tissue sources were used and compared in vivo to isograft control up to 24 weeks. Many axons and Schwann cells were shown migrating into the bridge, with few macrophages present. Both tissue sources were inferior to isograft control, contradicting previous results from the group in Wakimura et al. 2015. | [124,162] | ||||
| 1% SDS | 24 h | yes* | ||||||||
| Distilled water | 30 m | |||||||||
| 1% Triton X-100 | 1 h | yes* | ||||||||
| Distilled water | 30 m | |||||||||
| 100 U/mL penicillin-G, 100 ug/mL streptomycin, 0.25 ug/mL amphotericin B | 7d | |||||||||
| In vitro characterization | Rat sciatic nerve | N/A | N/A | 2x | 50 nM Tris buffer | 12 h | Comparisons were made to Sondell’s and Hudson’s methods. The proposed method showed a better removal of DNA content and preservation of ECM components. | [146,150,151,159,160,187,188] | ||
| 1% Triton X-100 in 50 nM Tris buffer at 4 °C | 24 h | |||||||||
| HBSS | 24 h | 24 | ||||||||
| 2x | 40,000 U/L DNase, 20 mg/L RNase, 100 mg/L Trypsin at 37C | 45 m | yes* | |||||||
| 1% Triton X-100 in 50 nM Tris buffer at 4 °C | 12 h | |||||||||
| 3x | HBSS at 4 °C | |||||||||
| 1.5 cm rat sciatic nerve defect | Porcine sciatic nerve | N/A | Processed into an ECM hydrogel | distilled water | 7 h | Resembling Sondell’s method, this study reduced washing steps to preserve ECM needed for gelation. The hydrogel was found to be superior using the altered method, but inferior to autograft control. | [189] | |||
| 3% Triton X-100 | 12 h | |||||||||
| 4% Sodium deoxycholate | 24 h | yes* | ||||||||
| 3x | distilled water | 15 m | yes* | |||||||
| Ethanol:Dichloromethane (1:2) distilled water | 24 h | |||||||||
| 1.5 cm rat sciatic nerve defect model | Porcine sciatic nerve | N/A | Processed into an ECM hydrogel | Distilled water | 14 h | 300 | The decellularized nerve ECM hydrogel was used as a lumen filler for a rat model of nerve gap injury. It showed increased regenerative bridge formation followed by enhanced M2 macrophage and Schwann cell migration and involvement. | [145] | ||
| 0.02% Trypsin/0.05% EDTA at 37 °C | 1 h | 300 | ||||||||
| 3% Triton X-100 | 1 h | 300 | ||||||||
| Distilled water | 300 | |||||||||
| 1 M Sucrose | 15 m | 300 | ||||||||
| 4% Sodium deoxycholate | 1 h | 300 | ||||||||
| 0.1% Peracetic acid/4% ethanol | 2 h | 300 | ||||||||
| 1X PBS | 15 m | 300 | ||||||||
| 2x | Distilled water | 15 m | 300 | |||||||
| 1X PBS | 15 m | 300 | ||||||||
| 1.5 cm rat sciatic nerve defect model | Rat sciatic nerve | N/A | N/A | Distilled water | 6 h | Method altered detergent combinations from Hudson’s method to reduce residual myelin. Comparing these two methods to the nerve autograft, the modified method had reduced immunogenicity and remyelination more comparable to autograft controls. However, morphologic assessment of axon regrowth showed no difference between the two methods. | [142] | |||
| 125 mM sulfobetaine-10 | 12 h | yes* | ||||||||
| 3x | 1X PBS | 10m | ||||||||
| 0.14% Triton X-200, 0.6 mM sulfobetaine-16 | 24 h | yes* | ||||||||
| 1X PBS | 10 m | |||||||||
| Distilled water | 10 m | |||||||||
| 125 mM sulfobetaine-10 | 12 h | yes* | ||||||||
| 4% Sodium deoxycholate | 24 h | yes* | ||||||||
| 3x | 1X PBS | 2 h | ||||||||
| 0.1% Peracetic acid | 3 h | |||||||||
| 3x | 1X PBS | 1 h | ||||||||
| Rabbit tibial nerve | Rabbit tibial and femoral nerves | N/A | N/A | Method 1: Hudson Method (control) | These methods limit hands-on time to prevent contamination and necessity of sterilization. Methods 2 and 3 were less harsh than Hudson’s method with small amount of DNA fragments and Schwann cells still present. Method 2 produced uneven decellularization towards the center of the graft. Method 3 did remove most of the myelin, axons, and DNA residue to a satisfactory degree with ECM preservation. | [121] | ||||
| 2x | 125mM SB-10, 10 mM phosphate, 50 mM sodium | 15 h | yes* | |||||||
| 0.14% Triton X-200, 0.6 mM SB-16, 10 mM phosphate, 50 mM sodium | 24 h | yes* | ||||||||
| Method 2: Triton X-100 based Method | ||||||||||
| 125 mM SB-10, 0.2% Triton X-100, 1% penicillin–streptomycin | 48 h | yes* | ||||||||
| Sonication at 40 Hz | 2m | |||||||||
| Method 3: Triton X-100 and SDS method | ||||||||||
| 125 mM SB-10, 0.2% Triton X-100, 1% penicillin–streptomycin freeze–thaw cycle | 48 h | |||||||||
| 3x | 1X PBS | 30 m | ||||||||
| 0.25% SDS and sonicated for 5 m every 30 m at 40 Hz | 3 h | |||||||||
| rat trigeminal, infraorbital sciatic nerve transection model | Porcine fetal urinary bladder matrix | N/A | Pressed and lyophilized into a sheet. ETO sterilized | 8x | Nanopure water | 30 m | The method uniquely included a chamber that cycled between ambient pressure and 0 psi at a rate of 1 min/cycle. The wrap enhanced epi- and endoneurial organization and increased angiogenesis; however, the number of axons and myelination were unchanged. | [161] | ||
| 3% Triton X-100 | 30 m | |||||||||
| 3 M NaCl | 30 m | |||||||||
| DNase | 1 h | |||||||||
| 0.1% Peracetic acid/4% ethanol 1X PBS | 1 h | |||||||||
| 3x | Nanopure water | |||||||||
| Rat sciatic nerve gap model looking at immunogenicity and mechanical properties | Rat sciatic nerve | N/A | N/A | Method 1: Sondell method (control) | The freeze-thaw method combined with enzymatic degradation showed the lowest immunogenicity of all methods tested. Also, fewer inflammatory cells were present and less necrosis seen at the downstream muscle with less MHC-II presentation compared to all other methods and native tissue. All decellularization techniques had similar mechanical properties to the native nerve. | [138] | ||||
| distilled water | 12 h | yes | ||||||||
| 2x | 3% Triton X-100 | 12 h | ||||||||
| 4% Sodium deoxycholate | 24 h | |||||||||
| Method 2: Low detergent method | ||||||||||
| ultrapure water | 1 h | yes | ||||||||
| 0.5% Triton X-100 | 48 h | yes | ||||||||
| ultrapure water | 48 h | |||||||||
| DNase and RNase at 37 °C | 12 h | |||||||||
| Method 3: Freeze-thaw method | ||||||||||
| hypotonic solution at 4 °C | 12 h | |||||||||
| hypotonic solution at −80 °C | 6 h | |||||||||
| hypotonic solution at 37 °C | 30 m | |||||||||
| 0.05% pancreatin | 6 h | |||||||||
| DNase and RNase at 37 °C | 12 h | |||||||||
| 1.5 cm rat sciatic nerve defect model | Rat cauda equina | N/A | Decellularized cauda equina allograft embedded within chitosan conduit | 3x | 1X PBS | Cauda equina source tissue used to test less harsh method because it lacks epineurium. This tissue required half the time (12 h) in SDS to achieve similar decellularization results to a sciatic nerve control (24 h). Cauda equina grafts performed better than other groups and similarly to autograft. | [123] | |||
| 0.5% SDS at 16 °C penicillin (100 U/mL) and streptomycin (0.1 mg/mL) in PBS | 12 h | 40 | ||||||||
| 10x | ||||||||||
| Rat sciatic nerve | 1X PBS | 12 h | ||||||||
| 10x | 1X PBS | |||||||||
| In vitro analysis | Porcine cauda equina | N/A | Homogenized cauda equina ECM with PLGA to form an electrospun scaffold | distilled water | Method incorporated insoluble proteins of the cauda equina ECM into an aligned, electrospun PLGA material. This incorporation of ECM proteins enhanced neurite outgrowth of dorsal root ganglion cells compared to PLGA material alone. | [148] | ||||
| 3% Triton X-100 | 2 h | yes | ||||||||
| 4% Sodium deoxycholate 1X PBS rinse Homogenized Centrifugation steps to isolate ECM precipitate | 2 h | yes | ||||||||
| In vitro analysis | Rat sciatic nerves | N/A | Nerve ECM coated onto PCL based conduits | distilled water | 15 m | Polydopamine (PDA) was coated onto polycaprolactone (PCL) conduits to successfully increase attachment of peripheral nerve ECM as a surface modification. This was shown to have potentially beneficial changes in Schwann cell behavior when cultured on the material in vitro. | [122] | |||
| 0.5% Triton X-100 in 1 M NaCl distilled water | 2 h | yes | ||||||||
| 1% SDS in 1 M NaCl distilled water, solution changed daily | 2d | yes | ||||||||
| 0.1% peracetic acid and 4% EtOH in 1 M NaCl | 4 h | |||||||||
| distilled water lyophilized | 4 h | |||||||||
| 1.0 cm rat sciatic nerve defect model | Rat sciatic nerve | Acellular nerve graft augmented with additional NGF or GDNF | N/A | 3x | Liquid nitrogen | 2m | Comparison of chondroitinase ABC treated acellular nerve grafts to NGF or GDNF imbibed grafts. NGF significantly enhanced motor axon outgrowth and number of myelinated axons. Sensory nerve outgrowth was significantly stunted. Dorsal root ganglion outgrowth in the presence of chondroitinase ABC and NGF showed no effect on sensory neurite outgrowth. | [172,173] | ||
| Thawed in water bath at 37 °C | 2 m | |||||||||
| 2 U/mL chondroitinase ABC in PBS at 37 °C | 16 h | |||||||||
| Incubated with NGF (10ug/mL) or GDNF (20 ug/mL) solution Rinsed in lactated Ringer solution | 1 h | |||||||||
| 2x | Rinsed in lactated Ringer solution | |||||||||
| Clinical study of digital nerve gaps > 2.5 cm | Human peripheral nerve | N/A | gamma irradiated | distilled water | 7 h | Applying the Avance decellularized nerve graft from Axogen, 86% of patients recovered meaningful function, matching autograft repair (60–80%). When studied in large diameter repairs, Avance decellularized graft was not limited in this regard and presented similar motor and sensory recovery as the gold-standard. In sensory repair applications, patients regained sensory function in 15 out of 16 cases with the Avance graft. | [149,153,155-157] | |||
| 125 mM sulfobetaine-10 | 15 h | yes* | ||||||||
| 50 mM phosphate and 100 mM sodium | 15 m | |||||||||
| Clinical study of large diameter cable repairs | 0.14% Triton X-200, 0.6 mM sulfobetaine-16, 10 mM phosphate and 50 mM sodium | 24 h | yes* | |||||||
| 3x | 50 mM phosphate and 100 mM sodium | 5 m | ||||||||
| 125 mM sulfobetaine-10 | 7 h | yes* | ||||||||
| Clinical study of trigeminal nerve repair | 50 mM phosphate and 100 mM sodium | 15 m | ||||||||
| 0.14% Triton X-200, 0.6 mM sulfobetaine-16, 10 mM phosphate and 50 mM sodium | 15 h | |||||||||
| 3x | 50 mM phosphate and 100 mM sodium Chondroitinase ABC at 37 °C | 15 m | ||||||||
| Crush | rabbit sciatic nerve crush model, clinical model of recurrent cubital tunnel syndrome | Porcine Small intestinal submucosa | N/A | Pressed and lyophilized into a sheet. ETO sterilized | Distilled water Delaminate tunica mucosa and tunica muscularis externa | Scaffold promoted vascularization and remodeling at implantation site. The product, AxoGuard Nerve Protector from AxoGen, showed enhanced grip and pinch strength as well as reduced pain levels for patients with chronic cubital tunnel syndrome. | [169,170] | |||
| 0.1% Peracetic acid/4% ethanol Distilled water | 2 h | |||||||||